These findings, along with the prognostic value of BRAF mutation, may have contributed the high thyroid cancer deaths (3103 deaths) in Indonesia, despite that papillary thyroid cancer had good survival rate [20]. This evidence concerns the gene BRAF and thyroid cancer.